Peptides for Psoriasis
The peptides people most often research for psoriasis, with how much evidence exists for each. A long list does not mean any of them is proven to work in people.
- Peptides listed
- 3
- With human trials
- 1
- FDA approved (any use)
- 0
- BPC-157Gastric pentadecapeptideAnimal evidence, 2 of 4Burns 2005, PMID 15774286Human0Animal0Summarised2PCAC voted 8–6 for 503A (Jul 2026)For psoriasisOverview
- TB-500Synthetic fragment of thymosin beta-4Human RCT evidence, 4 of 4Microbial biotechnology 2021, PMID 34318587Human3Animal0Summarised3PCAC voted 8–6 for 503A (Jul 2026)For psoriasisOverview
- KPVAnti-inflammatory tripeptideIn vitro evidence, 1 of 4Tissue & cell 2025, PMID 40073467Human0Animal0Summarised3PCAC voted 8–6 for 503A (Jul 2026)For psoriasisOverview
What this list does not show
Search demand tells you what people are curious about, not what works. Read each peptide's evidence before anything else.
Search interest is not evidence
This list follows what people search for and discuss. It says nothing about how well any peptide works.Animal results may not carry over
Doses, routes and effects seen in rodents or cell dishes often have no tested human equivalent.Approval covers specific uses
An FDA approval applies to the conditions and doses on the label, not to every goal a drug is searched with.Combinations are a separate question
Blends and stacks put several peptides together. Evidence for one peptide is not evidence for the mix.What psoriasis is
MedlinePlus describes psoriasis as a skin disease that causes itchy or sore patches of thick, red skin with silvery scales.[4]
MedlinePlus says a problem with the immune system causes psoriasis.[4]
What the listed peptides have been tested for
PubMed records matching the site's psoriasis search: BPC-157 0 human-only and 0 animal-only; TB-500 3 human-only and 0 animal-only; KPV 0 human-only and 0 animal-only.
Calculated from goal psoriasis; ledger date 2026-10-02; counts bpc-157 (human only 0, animal 0, rct 0), tb-500 (human only 3, animal 0, rct 0), kpv (human only 0, animal 0, rct 0). Formula: Copied from web/src/data/goals.json: peptides[].ledger.humanOnly.n and ledger.animal.n for this goal (PubMed title/abstract search, humans[mh] NOT animals vs animals NOT humans).
The nearest skin result is a different condition: in scalp seborrheic dermatitis, a recombinant thymosin beta-4 treatment provided significantly greater efficacy than ketoconazole.[2]
In adults with psoriatic arthritis and overweight or obesity, ACR50 response was 33.5% with ixekizumab plus tirzepatide versus 20.4% with ixekizumab alone (P = 0.02). This measures joint disease, not skin clearance.[5]
Common questions
Does BPC-157 or KPV work for psoriasis?
The site's PubMed ledger has 0 human-only and 0 animal-only psoriasis records for BPC-157 and KPV.
Calculated from goal psoriasis; counts bpc-157 (human only 0, animal 0, rct 0), kpv (human only 0, animal 0, rct 0). Formula: Copied from goals.json for goal 'psoriasis': peptides[].ledger.humanOnly.n, ledger.animal.n and ledger.rct.n.
Explore nearby goals
Sources
- 1The stable gastric pentadecapeptide BPC 157, given locally, improves CO2 laser healing in mice.Burns : journal of the International Society for Burn Injuries · 2005PMID 15774286Accessed 2 Oct 2026
- 2Recombinant human thymosin beta-4 (rhTβ4) improved scalp condition and microbiome homeostasis in seborrheic dermatitis.Microbial biotechnology · 2021PMID 34318587Accessed 2 Oct 2026
- 3Lysine-Proline-Valine peptide mitigates fine dust-induced keratinocyte apoptosis and inflammation by regulating oxidative stress and modulating the MAPK/NF-κB pathway.Tissue & cell · 2025PMID 40073467Accessed 2 Oct 2026
- 4Official web pageOfficial web page · web page
- 5Ixekizumab With Tirzepatide Achieved Greater Disease Control Than Ixekizumab Alone in Adults With Psoriatic Arthritis and Overweight or Obesity: Results From a Randomized Clinical Trial.Arthritis & rheumatology (Hoboken, N.J.) · 2026PMID 41903163Accessed 2 Oct 2026
Found an error? Report a correction.